<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE324nnn/GSE324025/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE324025</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Microglial sTREM2 limits dyskinesia and acts on TrkB to support circuit plasticity.</name><description>Microglia continuously survey the brain and shape neuronal activity, but their contribution to experience-dependent synaptic plasticity is unclear. Levodopa-induced dyskinesia (LID) is a disabling complication of late-stage Parkinson’s disease (PD) that is linked to maladaptive striatal remodeling and is often assumed to reflect detrimental neuroinflammation. Here we identify a dyskinesia-associated microglial gene program in the striatum of PD patients and show that microglia instead act as a protective brake on LID. In a mouse model, microglial depletion exacerbated dyskinesia, whereas microglial repopulation mitigated it. Delivery of AAV expressing soluble TREM2 (sTREM2) similarly reduced LID without impairing the therapeutic benefit of levodopa. Single-nucleus transcriptomics revealed that microglial loss drives extensive remodeling of both direct and indirect spiny projection neurons (SPNs), while repopulation or sTREM2 reverses a large fraction of LID-associated transcriptional changes. Mechanistically, sTREM2 directly engages TrkB and potentiates BDNF-dependent TrkB–ERK signaling, consistent with positive allosteric modulation. Functionally, sTREM2 enhances BDNF-TrkB-dependent hsciippocampal synaptic plasticity and acutely rebalances striatal dendritic excitability in a compartment- and cell type-specific manner. These findings reveal an unexpected neuroimmune pathway in which microglia restrain maladaptive plasticity via sTREM2–TrkB signaling, with therapeutic implications.</description><dates><publication>2026/08/03</publication></dates><accession>GSE324025</accession><cross_references><GSM>GSM9566903</GSM><GSM>GSM9566902</GSM><GSM>GSM9566869</GSM><GSM>GSM9566868</GSM><GSM>GSM9566901</GSM><GSM>GSM9566867</GSM><GSM>GSM9566900</GSM><GSM>GSM9566866</GSM><GSM>GSM9566865</GSM><GSM>GSM9566864</GSM><GSM>GSM9566863</GSM><GSM>GSM9566862</GSM><GSM>GSM9566909</GSM><GSM>GSM9566908</GSM><GSM>GSM9566907</GSM><GSM>GSM9566906</GSM><GSM>GSM9566905</GSM><GSM>GSM9566904</GSM><GSM>GSM9566914</GSM><GSM>GSM9566913</GSM><GSM>GSM9566879</GSM><GSM>GSM9566912</GSM><GSM>GSM9566911</GSM><GSM>GSM9566878</GSM><GSM>GSM9566910</GSM><GSM>GSM9566877</GSM><GSM>GSM9566876</GSM><GSM>GSM9566875</GSM><GSM>GSM9566874</GSM><GSM>GSM9566873</GSM><GSM>GSM9566872</GSM><GSM>GSM9566871</GSM><GSM>GSM9566870</GSM><GSM>GSM9566919</GSM><GSM>GSM9566918</GSM><GSM>GSM9566917</GSM><GSM>GSM9566916</GSM><GSM>GSM9566915</GSM><GSM>GSM9566889</GSM><GSM>GSM9566888</GSM><GSM>GSM9566887</GSM><GSM>GSM9566920</GSM><GSM>GSM9566886</GSM><GSM>GSM9566885</GSM><GSM>GSM9566884</GSM><GSM>GSM9566883</GSM><GSM>GSM9566882</GSM><GSM>GSM9566881</GSM><GSM>GSM9566880</GSM><GSM>GSM9566899</GSM><GSM>GSM9566898</GSM><GSM>GSM9566897</GSM><GSM>GSM9566896</GSM><GSM>GSM9566895</GSM><GSM>GSM9566894</GSM><GSM>GSM9566893</GSM><GSM>GSM9566892</GSM><GSM>GSM9566891</GSM><GSM>GSM9566890</GSM><GPL>24247</GPL><GSE>324025</GSE><taxon>Mus musculus</taxon><PMID>[42146496]</PMID></cross_references></HashMap>